Formulation Designing Factors for Development of Repaglinide Transdermal Therapeutic System. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 12, n. 2, p. 148–158, 2020. DOI: 10.25004/IJPSDR.2020.120209. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/1335.. Acesso em: 16 oct. 2025.